Skip Navigation
Department of Health and Human Services www.hhs.gov
 
Slide Tray
0 slides

Return to Slide Library

Slides

Add Presentation to Slide Tray Presentation:

Effectiveness of Recombinant Human Growth Hormone (rhGH) in the Treatment of Patients with Cystic Fibrosis

Slides: 13–24 of 37

Adverse Events of Interest in Studies of rhGH Treatment of Patients With CF

Controlled Trials of rhGH Treatment for CF Summarized in the CER

Characteristics of Trials of rhGH Treatment for Patients With CF

rhGH Effects on Intermediate Outcomes in Controlled Trials: Pulmonary Function

rhGH Effects on Health Outcomes Reported in Controlled Trials

Intermediate End Points and Health Outcomes in rhGH-Treated Patients With CF (1)

Intermediate End Points and Health Outcomes in rhGH-Treated Patients With CF (2)

Intermediate End Points and Health Outcomes in rhGH-Treated Patients With CF (3)

Intermediate End Points and Health Outcomes in rhGH-Treated Patients With CF (4)

Pages: Previous 1 [2] 3 4 Next